Breaking News Instant updates and real-time market news.

PGR

Progressive

$111.16 /

+1.45 (+1.32%)

08:22
05/18/22
05/18
08:22
05/18/22
08:22

Progressive reports April EPS (34c) vs. 54c last year

Reports net premiums written $4.82B vs. $4.45B last year. Reports net premiums earned $4.61B vs. $4.13B last year. Reports combined ratio 95.5% vs. 96% last year.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Ur-Energy signs agreement with U.S. nuclear utility » 17:35
08/08/22
08/08
17:35
08/08/22
17:35
URG

Ur-Energy

$1.18 /

-0.01 (-0.84%)

Ur-Energy announce that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
URG Ur-Energy
$1.18 /

-0.01 (-0.84%)

11/02/21 Alliance Global Partners
Ur-Energy price target raised to $2.50 from $2.20 at Alliance Global Partners
URG Ur-Energy
$1.18 /

-0.01 (-0.84%)

Earnings
Mesa Air reports Q3 EPS (28c), consensus (22c) » 17:34
08/08/22
08/08
17:34
08/08/22
17:34
MESA

Mesa Air

$2.66 /

+0.135 (+5.35%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MESA Mesa Air
$2.66 /

+0.135 (+5.35%)

MESA Mesa Air
$2.66 /

+0.135 (+5.35%)

05/11/22 Deutsche Bank
Mesa Air price target lowered to $3 from $5.50 at Deutsche Bank
02/04/22 Raymond James
Mesa Air downgraded to Market Perform from Outperform at Raymond James
02/04/22 Raymond James
Mesa Air downgraded to Market Perform from Outperform at Raymond James
01/07/22 BofA
Mesa Air downgraded to Neutral from Buy at BofA
MESA Mesa Air
$2.66 /

+0.135 (+5.35%)

Hot Stocks
National Healthcare announces $25M stock repurchase authorization » 17:31
08/08/22
08/08
17:31
08/08/22
17:31
NHC

National Healthcare

$69.31 /

+1.14 (+1.67%)

National HealthCare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NHC National Healthcare
$69.31 /

+1.14 (+1.67%)

NHC National Healthcare
$69.31 /

+1.14 (+1.67%)

Hot Stocks
CorMedix receives CRL from FDA saying that DefenCath NDA cannot be approved » 17:31
08/08/22
08/08
17:31
08/08/22
17:31
CRMD

CorMedix

$7.50 /

+0.39 (+5.49%)

CorMedix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRMD CorMedix
$7.50 /

+0.39 (+5.49%)

CRMD CorMedix
$7.50 /

+0.39 (+5.49%)

CRMD CorMedix
$7.50 /

+0.39 (+5.49%)

Syndicate
Cyteir Therapeutics files $300M mixed securities shelf  17:30
08/08/22
08/08
17:30
08/08/22
17:30
CYT

Cyteir Therapeutics

$2.58 /

+0.09 (+3.61%)

 
ShowHide Related Items >><<
CYT Cyteir Therapeutics
$2.58 /

+0.09 (+3.61%)

CYT Cyteir Therapeutics
$2.58 /

+0.09 (+3.61%)

03/17/22 Wedbush
Cyteir Therapeutics price target lowered to $30 from $40 at Wedbush
02/07/22 Northland
Cyteir Therapeutics initiated with an Outperform at Northland
CYT Cyteir Therapeutics
$2.58 /

+0.09 (+3.61%)

Syndicate
Biolase files to sell 1.41M shares of common stock for holders  17:30
08/08/22
08/08
17:30
08/08/22
17:30
BIOL

Biolase

$5.40 /

+0.12 (+2.27%)

 
ShowHide Related Items >><<
BIOL Biolase
$5.40 /

+0.12 (+2.27%)

BIOL Biolase
$5.40 /

+0.12 (+2.27%)

05/20/22 Lake Street
Biolase initiated with a Buy at Lake Street
08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
BIOL Biolase
$5.40 /

+0.12 (+2.27%)

Syndicate
CinCor Pharma files to sell 6M shares of common stock, pre-funded warrants » 17:29
08/08/22
08/08
17:29
08/08/22
17:29
CINC

CinCor Pharma

$34.96 /

+11.46 (+48.77%)

Goldman Sachs & Co.,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

14:35 Today Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
02/01/22 Evercore ISI
CinCor Pharma initiated with an Outperform at Evercore ISI
CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

  • 07
    Jan
CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

Earnings
Primoris reports Q2 adjusted EPS 48c, two estimates 59c » 17:29
08/08/22
08/08
17:29
08/08/22
17:29
PRIM

Primoris

$22.52 /

+0.095 (+0.42%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRIM Primoris
$22.52 /

+0.095 (+0.42%)

PRIM Primoris
$22.52 /

+0.095 (+0.42%)

11/10/21 Goldman Sachs
Goldman downgrades Primoris to Sell on 'bottom quintile' growth
11/10/21 Goldman Sachs
Primoris downgraded to Sell from Neutral at Goldman Sachs
PRIM Primoris
$22.52 /

+0.095 (+0.42%)

Syndicate
Merchants Bancorp files $500M mixed securities shelf  17:27
08/08/22
08/08
17:27
08/08/22
17:27
MBIN

Merchants Bancorp

$27.72 /

+0.445 (+1.63%)

 
ShowHide Related Items >><<
MBIN Merchants Bancorp
$27.72 /

+0.445 (+1.63%)

MBIN Merchants Bancorp
$27.72 /

+0.445 (+1.63%)

Earnings
Freshpet backs FY22 revenue view of at least $575M, consensus $582.72M » 17:27
08/08/22
08/08
17:27
08/08/22
17:27
FRPT

Freshpet

$56.39 /

+1.895 (+3.48%)

Sees FY22 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

05/20/22 Atlantic Equities
Atlantic Equities sees more volatility for Freshpet, downgrades shares
05/20/22 Atlantic Equities
Freshpet downgraded to Neutral from Overweight at Atlantic Equities
05/03/22 Cowen
Freshpet price target lowered to $163 from $181 at Cowen
05/03/22 Oppenheimer
Freshpet price target lowered to $110 from $120 at Oppenheimer
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

  • 04
    May
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

Syndicate
Rallybio files $300M mixed securities shelf  17:25
08/08/22
08/08
17:25
08/08/22
17:25
RLYB

Rallybio

$10.61 /

-0.54 (-4.84%)

 
ShowHide Related Items >><<
RLYB Rallybio
$10.61 /

-0.54 (-4.84%)

RLYB Rallybio
$10.61 /

-0.54 (-4.84%)

02/22/22 JMP Securities
Rallybio initiated with an Outperform at JMP Securities
08/23/21 Evercore ISI
Rallybio initiated with an Outperform at Evercore ISI
08/23/21 Cowen
Rallybio initiated with an Outperform at Cowen
08/23/21 Jefferies
Rallybio initiated with a Buy at Jefferies
RLYB Rallybio
$10.61 /

-0.54 (-4.84%)

Earnings
Freshpet reports Q2 EPS (45c), consensus (14c) » 17:25
08/08/22
08/08
17:25
08/08/22
17:25
FRPT

Freshpet

$56.39 /

+1.895 (+3.48%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

05/20/22 Atlantic Equities
Atlantic Equities sees more volatility for Freshpet, downgrades shares
05/20/22 Atlantic Equities
Freshpet downgraded to Neutral from Overweight at Atlantic Equities
05/03/22 Cowen
Freshpet price target lowered to $163 from $181 at Cowen
05/03/22 Oppenheimer
Freshpet price target lowered to $110 from $120 at Oppenheimer
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

  • 04
    May
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

Conference/Events
CTI BioPharma management to meet virtually with BTIG » 17:25
08/08/22
08/08
17:25
08/08/22
17:25
CTIC

CTI BioPharma

$7.04 /

-0.38 (-5.12%)

In conjunction with the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTIC CTI BioPharma
$7.04 /

-0.38 (-5.12%)

CTIC CTI BioPharma
$7.04 /

-0.38 (-5.12%)

11:28 Today Stifel
Global Blood Therapeutics downgraded to Hold from Buy at Stifel
07/07/22 Cowen
Cowen starts CTI BioPharma at Outperform on 'high growth opportunity'
07/07/22 Cowen
CTI BioPharma initiated with an Outperform at Cowen
04/14/22 Stifel
Stifel reiterates Buy on CTI BioPharma following new treatment guidelines
CTIC CTI BioPharma
$7.04 /

-0.38 (-5.12%)

CTIC CTI BioPharma
$7.04 /

-0.38 (-5.12%)

CTIC CTI BioPharma
$7.04 /

-0.38 (-5.12%)

Conference/Events
Legend Biotech management to meet with BTIG » 17:25
08/08/22
08/08
17:25
08/08/22
17:25
LEGN

Legend Biotech

$49.50 /

-0.385 (-0.77%)

BTIG Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LEGN Legend Biotech
$49.50 /

-0.385 (-0.77%)

LEGN Legend Biotech
$49.50 /

-0.385 (-0.77%)

07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
06/16/22 BMO Capital
Legend Biotech initiated with an Outperform at BMO Capital
05/31/22 Morgan Stanley
Legend Biotech named Catalyst Driven Idea by Morgan Stanley
03/15/22 Barclays
Legend Biotech initiated with an Overweight at Barclays
LEGN Legend Biotech
$49.50 /

-0.385 (-0.77%)

  • 27
    Jul
  • 16
    Dec
LEGN Legend Biotech
$49.50 /

-0.385 (-0.77%)

LEGN Legend Biotech
$49.50 /

-0.385 (-0.77%)

Conference/Events
Liquidia Technologies management to meet with BTIG » 17:25
08/08/22
08/08
17:25
08/08/22
17:25
LQDA

Liquidia Technologies

$5.35 /

-0.01 (-0.19%)

In conjunction with the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LQDA Liquidia Technologies
$5.35 /

-0.01 (-0.19%)

LQDA Liquidia Technologies
$5.35 /

-0.01 (-0.19%)

07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
07/22/22 Ladenburg
Liquidia Technologies initiated with a Buy at Ladenburg
07/20/22 BTIG
Liquidia Technologies price target raised to $17 from $14 at BTIG
05/31/22 BTIG
Liquidia Technologies initiated with a Buy at BTIG
LQDA Liquidia Technologies
$5.35 /

-0.01 (-0.19%)

  • 15
    Apr
LQDA Liquidia Technologies
$5.35 /

-0.01 (-0.19%)

Conference/Events
Andersons management to meet with Stephens » 17:25
08/08/22
08/08
17:25
08/08/22
17:25
ANDE

Andersons

$37.90 /

-0.05 (-0.13%)

Stephens holds a group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANDE Andersons
$37.90 /

-0.05 (-0.13%)

ANDE Andersons
$37.90 /

-0.05 (-0.13%)

05/05/22 BMO Capital
Andersons price target lowered to $45 from $50 at BMO Capital
03/25/22 Lake Street
Andersons price target raised to $60 from $50 at Lake Street
02/17/22 Lake Street
Andersons price target raised to $50 from $45 at Lake Street
11/29/21 Lake Street
Andersons price target raised to $45 from $42 at Lake Street
ANDE Andersons
$37.90 /

-0.05 (-0.13%)

Syndicate
Cybin announces at-the-market equity program for up to $35M » 17:23
08/08/22
08/08
17:23
08/08/22
17:23
CYBN

Cybin

/

+

Cybin "announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYBN Cybin
/

+

CYBN Cybin
/

+

06/23/22 Canaccord
Cybin undervalued relative to market size opportunity, says Canaccord
06/10/22 Canaccord
Cybin shares remain significantly undervalued, says Canaccord
04/13/22 H.C. Wainwright
H.C. Wainwright says Cybin preclinical data show continued innovation leadership
11/23/21 Stifel
Cybin price target lowered to C$8.25 from C$10 at Stifel
CYBN Cybin
/

+

Hot Stocks
Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056 » 17:22
08/08/22
08/08
17:22
08/08/22
17:22
MRSN

Mersana Therapeutics

$5.24 /

+0.215 (+4.28%)

, GSK

GSK plc

$40.31 /

-0.27 (-0.67%)

Mersana Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

05/10/22 Baird
Mersana Therapeutics price target lowered to $18 from $23 at Baird
05/09/22 H.C. Wainwright
Mersana price target lowered to $19 from $24 at H.C. Wainwright
11/10/21 Baird
Mersana Therapeutics price target lowered to $23 from $30 at Baird
10/14/21 BTIG
Mersana Therapeutics assumed with a Buy at BTIG
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

14:58 Today UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
08/05/22 Morgan Stanley
GSK plc resumed with an Equal Weight at Morgan Stanley
07/21/22 Citi
GSK plc resumed with a Neutral at Citi
07/20/22 UBS
GSK plc price target lowered to 1,850 GBp from 1,876 GBp at UBS
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

Syndicate
Canoo files automatic mixed securities shelf  17:22
08/08/22
08/08
17:22
08/08/22
17:22
GOEV

Canoo

$3.95 /

+0.26 (+7.05%)

 
ShowHide Related Items >><<
GOEV Canoo
$3.95 /

+0.26 (+7.05%)

GOEV Canoo
$3.95 /

+0.26 (+7.05%)

07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
12/16/21 R.F. Lafferty
Canoo price target raised to $21 from $19 at R.F. Lafferty
12/16/21 Roth Capital
Roth Capital upgrades Canoo to Buy, raises price target to $14
GOEV Canoo
$3.95 /

+0.26 (+7.05%)

GOEV Canoo
$3.95 /

+0.26 (+7.05%)

GOEV Canoo
$3.95 /

+0.26 (+7.05%)

GOEV Canoo
$3.95 /

+0.26 (+7.05%)

Earnings
Aterian reports Q2 EPS (26), consensus (12c) » 17:22
08/08/22
08/08
17:22
08/08/22
17:22
ATER

Aterian

$2.97 /

+0.225 (+8.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATER Aterian
$2.97 /

+0.225 (+8.20%)

ATER Aterian
$2.97 /

+0.225 (+8.20%)

03/11/22 Alliance Global Partners
Aterian price target lowered to $4.50 from $9 at Alliance Global Partners
03/09/22 BTIG
Aterian price target lowered to $5 from $9 at BTIG
03/09/22 DA Davidson
Aterian price target lowered to $7 from $14 at DA Davidson
02/11/22 Alliance Global Partners
Aterian price target lowered to $9 from $13 at Alliance Global Partners
ATER Aterian
$2.97 /

+0.225 (+8.20%)

ATER Aterian
$2.97 /

+0.225 (+8.20%)

ATER Aterian
$2.97 /

+0.225 (+8.20%)

Earnings
Granite Point Mortgage reports Q2 EPS 22c, consensus 22c » 17:21
08/08/22
08/08
17:21
08/08/22
17:21
GPMT

Granite Point Mortgage

$10.43 /

+0.1 (+0.97%)

Jack Taylor, President,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Earnings
Inhibrx reports Q2 EPS (97c), consensus (78c) » 17:21
08/08/22
08/08
17:21
08/08/22
17:21
INBX

Inhibrx

$24.67 /

+1.56 (+6.75%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INBX Inhibrx
$24.67 /

+1.56 (+6.75%)

INBX Inhibrx
$24.67 /

+1.56 (+6.75%)

03/15/22 SMBC Nikko
Inhibrx initiated with an Outperform at SMBC Nikko
03/15/22 SMBC Nikko
Inhibrx initiated with an Outperform at SMBC Nikko
11/10/21 Credit Suisse
Inhibrx price target raised to $53 from $44 at Credit Suisse
11/02/21 JMP Securities
Inhibrx price target raised to $53 from $46 at JMP Securities
INBX Inhibrx
$24.67 /

+1.56 (+6.75%)

Earnings
Prothena reports Q2 EPS (88c) vs. 58c last year » 17:19
08/08/22
08/08
17:19
08/08/22
17:19
PRTA

Prothena

$33.07 /

+0.01 (+0.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRTA Prothena
$33.07 /

+0.01 (+0.03%)

PRTA Prothena
$33.07 /

+0.01 (+0.03%)

05/25/22 JMP Securities
Prothena price target lowered to $50 from $77 at JMP Securities
02/18/22 Citi
Prothena price target lowered to $73 from $87 at Citi
11/19/21 JMP Securities
Prothena initiated with an Outperform at JMP Securities
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
PRTA Prothena
$33.07 /

+0.01 (+0.03%)

Earnings
Clover Health reports Q2 revenue $846.7M, consensus $814.62M » 17:16
08/08/22
08/08
17:16
08/08/22
17:16
CLOV

Clover Health

$3.40 /

+0.14 (+4.30%)

Reports total lives under…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLOV Clover Health
$3.40 /

+0.14 (+4.30%)

CLOV Clover Health
$3.40 /

+0.14 (+4.30%)

02/24/22 Canaccord
Clover Health price target raised to $7 from $6 at Canaccord
02/17/22 Citi
Citi opens 'negative catalyst watches' in health care services
02/02/22 Cowen
Clover Health upgraded to Market Perform from Underperform at Cowen
01/19/22 SVB Leerink
Clover Health initiated with a Market Perform at SVB Leerink
CLOV Clover Health
$3.40 /

+0.14 (+4.30%)

  • 18
    Nov
CLOV Clover Health
$3.40 /

+0.14 (+4.30%)

CLOV Clover Health
$3.40 /

+0.14 (+4.30%)

Periodicals
'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says » 17:14
08/08/22
08/08
17:14
08/08/22
17:14
SONY

Sony

$84.84 /

-1.46 (-1.69%)

, NTDOY

Nintendo

$53.24 /

-0.82 (-1.52%)

, WBD

Warner Bros. Discovery

$14.01 /

-0.58 (-3.98%)

, MSFT

Microsoft

$280.35 /

-2.78 (-0.98%)

, EA

Electronic Arts

$131.09 /

-1.48 (-1.12%)

PlayStation (SONY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SONY Sony
$84.84 /

-1.46 (-1.69%)

NTDOY Nintendo
$53.24 /

-0.82 (-1.52%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

MSFT Microsoft
$280.35 /

-2.78 (-0.98%)

EA Electronic Arts
$131.09 /

-1.48 (-1.12%)

SONY Sony
$84.84 /

-1.46 (-1.69%)

07/08/22 Macquarie
Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie
07/05/22 Citi
Sony downgraded to Neutral from Buy at Citi
05/18/22 Oppenheimer
Sony price target lowered to $125 from $150 at Oppenheimer
04/13/22 CLSA
Sony downgraded to Outperform from Buy at CLSA
NTDOY Nintendo
$53.24 /

-0.82 (-1.52%)

05/24/22 CLSA
Nintendo price target lowered to 51,000 yen from 53,000 yen at CLSA
03/23/22 Macquarie
Nintendo upgraded to Outperform from Neutral at Macquarie
02/16/22 Jefferies
Nintendo upgraded to Buy from Hold at Jefferies
11/05/21 Macquarie
Nintendo downgraded to Neutral from Outperform at Macquarie
WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

09:00 Today Barrington
Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
08/05/22 Wells Fargo
Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
08/05/22 Barclays
Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
08/04/22 Credit Suisse
Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
MSFT Microsoft
$280.35 /

-2.78 (-0.98%)

09:27 Today B. Riley
B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
08/04/22 MKM Partners
8x8 initiated with a Neutral at MKM Partners
08/04/22 Deutsche Bank
Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank
08/03/22 Craig-Hallum
RingCentral price target lowered to $110 from $175 at Craig-Hallum
EA Electronic Arts
$131.09 /

-1.48 (-1.12%)

08/04/22 Wells Fargo
Electronic Arts price target raised to $155 from $145 at Wells Fargo
08/03/22 Morgan Stanley
PayPal price target raised to $134 from $129 at Morgan Stanley
08/03/22 Credit Suisse
Electronic Arts price target lowered to $154 from $159 at Credit Suisse
08/03/22 BofA
Electronic Arts price target raised to $155 from $148 at BofA
SONY Sony
$84.84 /

-1.46 (-1.69%)

NTDOY Nintendo
$53.24 /

-0.82 (-1.52%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

MSFT Microsoft
$280.35 /

-2.78 (-0.98%)

EA Electronic Arts
$131.09 /

-1.48 (-1.12%)

SONY Sony
$84.84 /

-1.46 (-1.69%)

NTDOY Nintendo
$53.24 /

-0.82 (-1.52%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

MSFT Microsoft
$280.35 /

-2.78 (-0.98%)

EA Electronic Arts
$131.09 /

-1.48 (-1.12%)

SONY Sony
$84.84 /

-1.46 (-1.69%)

NTDOY Nintendo
$53.24 /

-0.82 (-1.52%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

MSFT Microsoft
$280.35 /

-2.78 (-0.98%)

EA Electronic Arts
$131.09 /

-1.48 (-1.12%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

MSFT Microsoft
$280.35 /

-2.78 (-0.98%)

EA Electronic Arts
$131.09 /

-1.48 (-1.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.